Professional
Added to YB: 2025-12-05
Pitch date: 2025-10-30
DERM [neutral]
Journey Medical Corporation
-8.09%
current return
Author Info
No bio for this author
Company Info
Journey Medical Corporation, a commercial-stage pharmaceutical company that focuses on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States.
Market Cap
$177.0M
Pitch Price
$8.16
Price Target
20.00 (+194%)
Dividend
N/A
EV/EBITDA
119.72
P/E
-28.15
EV/Sales
2.60
Sector
Pharmaceuticals
Category
growth
Summers Value Partners Portfolio Holding: Journey Medical Corporation
DERM (holding update): Dermatology co w/ new Emrosi rosacea treatment hitting $30M annualized sales in 6 months post-launch. Positive feedback suggests $100M+ peak sales potential. Profitable by 2026 via scalable model. Acquisition candidate amid industry consolidation. $20 price target.
Read full article (1 min)